Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The company is further exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treating/preventing a variety of conditions including: gastrointestinal diseases, immuno-oncology, metabolic, and liver disease.
| Website: | www.ritterpharmaceuticals.com |
| Main Phone: | +1 310 203-1000 |
| Address: | 1880 Century Park East |
| Address 2: | Suite 1000 |
| State: | CA |
| City / Town: | Los Angeles |
| Country: | USA |
| Postal Code: | 90067 |
| Exchange: | NSC |
| CEO: | Andrew J. Ritter |
| Employees: | 7 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Gathering Data... Please wait Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The company is further exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treating/preventing a variety of conditions including: gastrointestinal diseases, immuno-oncology, metabolic, and liver disease.
| Website: | www.ritterpharmaceuticals.com |
| Main Phone: | +1 310 203-1000 |
| Address: | 1880 Century Park East |
| Address 2: | Suite 1000 |
| State: | CA |
| City / Town: | Los Angeles |
| Country: | USA |
| Postal Code: | 90067 |
| Exchange: | NSC |
| CEO: | Andrew J. Ritter |
| Employees: | 7 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 0.32 | Change $ -0.005 | Change % -1.54 | Tick N/A |
| Bid 0.31 | Bid Size 2,300.00 | Ask 0.32 | Ask Size 1,400.00 |
| Open 0.33 | High 0.34 | Low 0.30 | Prev Close 0.32 |
| Last Trade | Volume 1.7 mi | 52 Wk Hi 2.56 | 52 Wk Low 0.29 |
| Market Cap 3 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 9,426,950.00 | EPS (TTM) -3.41 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 3 |
| Number of Buys | 0 | 3 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 5375000 |
| Last 10 Buys | Shares |
|---|---|
| Andrew J. Ritter | 1,000 |
| Ira E. Ritter | 1,000 |
| Noah J. Doyle | 1,000 |
| Matthew W. Foehr | 1,000 |
| Michael D. Step | 1,000 |
| Michael D. Step | 1,000 |
| Michael D. Step | 1,000 |
| Ira E. Ritter | 1,000 |
| Andrew J. Ritter | 1,000 |
| Matthew W. Foehr | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 15 | 15 | 15 | 15 |
| Low Target Price Estimate | 12 | 12 | 12 | 12 |
| Mean Target Price Estimate | 13.5 | 13.5 | 13.5 | 13.5 |
| Standard Deviation | 2.12 | 2.12 | 2.12 | 2.12 |
| Date of Most Recent Estimate | 05/29/18 | 05/29/18 | 05/16/18 | 05/29/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 20 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-25 |
| DEFA14A | Additional proxy soliciting materials - definitive | 6 | 2018-05-25 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2018-05-15 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 31 | 2018-05-15 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 43 | 2018-05-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 37 | 2018-05-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-04-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-03-22 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1.67 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
